Joseph Ciccolini

22PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Human biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 12, 2026
The Impact of Upfront DihydroPyrimidine Dehydrogenase (DPD) Testing on the Therapeutic Management of Patients Scheduled for 5-FU.

|Sep 10, 2025
Eco Friendly and Budget Smart: An Economic and Environmental Evaluation of Alternative PD-1 and PD-L1 Inhibitor Dosing Regimens.

Leo Karlsson, Joseph Ciccolini, Rob Ter Heine

|Jul 07, 2025
DPD Ultra-Rapid Metabolizer Status and Efficacy of 5-Fluorouracil Treatment: A Real-World Study.

Govind Kallee, Gérard Milano, Florence Duffaud

|Jan 03, 2025
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing.

Paul Maroselli, Raphaelle Fanciullino, Julien Colle

|Nov 20, 2024
Adaptive dosing of high-dose busulfan in real-world adult patients undergoing haematopoietic cell transplant conditioning.

Dorian Protzenko, Benjamin Bouchacourt, Laure Carriat

|Nov 27, 2023
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patients.

Sophie Marolleau, Alice Mogenet, Clara Boeri

Pageof 4

Frequent Collaborators

2 joint publications

Fabienne Thomas

2 joint publications

Govind Kallee

2 joint publications

Mourad Hamimed

2 joint publications

Caroline Solas